跳至主要内容
临床试验/NCT06305195
NCT06305195招募中不适用

Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome: Impact of Some Antidiabetic Drugs

Alexandria University1 个研究点 分布在 1 个国家目标入组 155 人开始时间: 2023年8月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
155
试验地点
1
主要终点
body mass index

研究概览

简要总结

The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic individuals.

Heart rate variability will be compared for some antidiabetic drugs used in different stages of metabolic diseases and correlated to different metabolic and inflammatory mediators.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-diabetic individuals: adults (18-70 Years) with glycated hemoglobin (HBA1C)<5.7 and/or Fasting blood glucose <100 mg/L and with no classic symptoms of hyperglycemia
  • Pre-diabetic: adults (18-70 Years) who fulfil one of the American Diabetes Association (ADA) criteria :
  • glycated hemoglobin (HBA1C) =5.7-6.4%
  • Fasting blood glucose level = 100 mg/dL to 125 mg/dL. Fasting is defined as no caloric intake for at least 8 hours.
  • Diabetic patients: adults (18-70 Years) who fulfil one of the American Diabetes Association (ADA) criteria:
  • glycated hemoglobin (HBA1C) ≥6.5%
  • Fasting blood glucose ≥126 mg/dL.
  • A random plasma glucose ≥200 mg/dL. Random is any time of the day without regard to the meals.

排除标准

  • Pediatric and elderly subjects
  • Pregnant subjects
  • Those with active Myocardial infarction
  • Those with acute decompensated heart failure
  • Patients with pacemaker
  • Patients with persistent Atrial fibrillation, long-standing persistent and permanent Atrial fibrillation

结局指标

主要结局

body mass index

时间窗: one year

Measuring body weight in kilograms (kg) and height in centimeters (cm) to calculate the Body Mass Index (BMI) in kg/m\^2, a key indicator of healthy weight that can help identify potential health risks.

Valsalva ratio

时间窗: one year

The Valsalva ratio is the proportion of the highest and lowest heart rate during and immediately after performing a Valsalva maneuver. A value of 1.21 or more is defined as a normal response

Beat-to-beat Heart rate variability

时间窗: one year

•It will be measured Different stages of metabolic diseases among non-diabetic, diabetic and prediabetic subjects

Stand 30:15 ratio

时间窗: one year

The Stand 30:15 ratio is the ratio of the highest heart rate during (occurring approximately 15 sec after the initiation of standing) and immediately following standing up from a supine position (occurring approximately 30 sec after the initiation of standing).

deep breath test interpretation

时间窗: one year

The heart rate response to deep breathing test was calculated as the difference between maximum heart rate during inhalation and minimum heart rate during exhalation. A difference of 15 beats/min or more is considered parasympathetic activation.

次要结局

  • Framingham risk score (FRS)(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hala Abo El Hassan

Teacher assistant

Alexandria University

研究点 (1)

Loading locations...

相似试验